Richard Unwin
LightNews LightNews
banner
rdunwin.bsky.social
Richard Unwin
@rdunwin.bsky.social
870 followers 450 following 390 posts
Mass Spectrometry and proteomics at Uni of Manchester. Analysis of primary samples for biomarker discovery. Development of targeted assays for clinical use.

Co-founder, Complement Therapeutics

Also football (SWFC), cricket and politics.
Posts Replies Media Videos
Reposted by Richard Unwin
slavov-n.bsky.social
A special opportunity for lovers of mass spectrometry proteomics to join a like-minded team at PTI.

Join a collaborative initiative to enable direct protein analysis at unprecedented scale, in partnership with leading instrument developers, academics, and industry leaders.

1/2
February 4, 2026 at 1:00 PM
rdunwin.bsky.social
Noooooo

This is so sad. Grew up watching him play. Watching him entertain. And listening to him commentate. Mr Snooker.

Always came across as a genuinely lovely and funny bloke too. Gonna be really missed.

#RIPJV #bbcsnooker

www.bbc.co.uk/sport/snooke...
John Virgo dies aged 79
John Virgo, who co-presented TV show Big Break and commentated on the BBC for 47 years, has died.
www.bbc.co.uk
February 4, 2026 at 9:59 AM
Reposted by Richard Unwin
robinbisson.bsky.social
Asked about paused funding calls at research councils, Chapman said that at BBSRC:

"We’re going to pause gently while we reorient the system to be always open, so it will paused just for matter of a few weeks"

"On MRC...that pause I expect will run until early summer and then will be open again"
February 3, 2026 at 11:51 AM
Reposted by Richard Unwin
mtrost.bsky.social
I have a 3-year postdoc position available at University of Manchester for a mass spec expert in proteomics. The person will be involved in exciting projects in single cell proteomics, drug discovery and innate immunity - on timsTOF Ultra AIP & HF & Astral Zoom.

www.jobs.ac.uk/job/DQJ093/r...
Home - Trost Lab
www.trostlab.org
February 2, 2026 at 7:53 PM
rdunwin.bsky.social
Rumours of 'more news in spring', which likely means no rounds until summer and no money being released until 2027 at the earliest. Given the virtual cancellation of the current round, where applicants and reviewers have already poured thousands of hours of work and effort, that's a 12 month gap.
iansudbery.bsky.social Ian Sudbery @iansudbery.bsky.social · 5d
We need to be shouting about the effects of this on junior researchers from the roofs, writing to our MPs. We are risking a "missing generation" of researchers.
February 1, 2026 at 10:57 AM
rdunwin.bsky.social
Wow 😱
January 30, 2026 at 9:37 AM
Reposted by Richard Unwin
uomif.bsky.social
Congrats to spinouts KOKU Health (Prof Emma Stanmore) & Spotlight Pathology (Martin Fergie/Richard Byers) & Maria Giovanna Lizio (WILD Imaging Technologies) on being shortlisted for BioNow Awards!
January 29, 2026 at 12:32 PM
rdunwin.bsky.social
😭😭😭😭

If this happens, and it looks likely, the club will have lost one of its best ever servants.

Not enough words to say thank you for all he's done for #swfc.

I know it's not what he would have chose. Gutted is an understatement. #wawaw

www.bbc.co.uk/sport/footba...
Barry Bannan: Sheffield Wednesday captain set to leave club
Sheffield Wednesday captain Barry Bannan tells team-mates that Saturday's game at Bristol City will be his last for the club.
www.bbc.co.uk
January 23, 2026 at 3:54 PM
rdunwin.bsky.social
It would be typically Wednesday if Barry Bannan's first game for a new club happens to be against us at Hillsborough on Valentine's Day #swfc #justsaying
swfc.co.uk Sheffield Wednesday @swfc.co.uk · 16d
Every season, the Owls Foundation gives its members three discounted fixtures in the second half of the campaign.

This year, the first of those games is Wednesday v Millwall on Valentine’s Day!

🔗 t.co/yPtmdGXC7f
January 21, 2026 at 3:14 PM
Reposted by Richard Unwin
wvschaik.bsky.social
UKRI pauses several funding calls amid priorities shake-up

The applicant-led MRC funding calls on pause include research grants, partnership grants and new investigator research grants made available through the council’s research boards.

www.researchprofessional.com/news-article...
Research Professional Sign-in
www.researchprofessional.com
January 19, 2026 at 5:24 PM
Reposted by Richard Unwin
prof-clark.bsky.social
An opportunity for someone to join our team! We're looking for a 50% Technical Assistant from Feb. 2026 - Dec. 2030

Application deadline 15th Jan 2026! Please see
Technical Assistant
The Institute for Ophthalmic Research (IOR), part of the Centre for Ophthalmology at the University Medical Centre Tübingen, offers excellent infrastructure and a dynamic basic and clinical research…
buff.ly
January 9, 2026 at 9:39 AM
Reposted by Richard Unwin
dervissalih1.bsky.social
December 25, 2025 at 1:46 PM
Reposted by Richard Unwin
rhodri.biz
Twas the night before Christmas, and throughout the land
The sleeping arrangements were carefully planned
Down in the kitchen, a picturesque scene
A mattress, a pillow, a washing machine
December 24, 2025 at 7:30 PM
rdunwin.bsky.social
This remains one of the BEST social media threads of the year. If you've never seen it, check it out (and if you're a long-time duvet-er, enjoy!) 😁
rhodri.biz Rhodri Marsden @rhodri.biz · Dec 23
Tomorrow evening it’ll be my annual duty to vaguely shepherd the activity on the #duvetknowitschristmas hashtag and urge people to give small sums to charity. 7.30pm? Something like that?
December 23, 2025 at 9:00 PM
rdunwin.bsky.social
Sad news about #ChrisRea. Was a bit of a fan when I was growing up.

Predictable focus on 'Driving home for Christmas'. But it's not even his best Christmas song lol.

If you've not heard it, check this. The Intro is 🔥, and the lyrics are top drawer

Thanks, Chris. RiP

youtu.be/nYz21xcJxTs?...
Joys of Christmas
YouTube video by Chris Rea - Topic
youtu.be
December 22, 2025 at 7:50 PM
Reposted by Richard Unwin
wrenkh.bsky.social
Just a gentle reminder to anyone who needs this...

Please share with your followers. You might be surprised who it could help...
During the Christmas holidays it's ok if you don't get on with your family your weight changes you need some time to yourself you say no to some parties you don't feel like cooking you're not drinking
December 21, 2025 at 10:39 PM
rdunwin.bsky.social
Dear the entire USA. You guys know that this is not normal, right? 🤦‍♂️😬
deathofbuckley.bsky.social BUCKERS @deathofbuckley.bsky.social · Dec 18
In today’s episode of “I am Mental” x
December 18, 2025 at 8:45 AM
Reposted by Richard Unwin
mtrost.bsky.social
I have a PhD position available with start date September 2026 at the University of Manchester.

Proteomics analysis of flow cytometry-based isolated pathogen-containing phagosomes

Due to funding requirements, this position is for UK home students only.

www.findaphd.com/phds/project...
Proteomics analysis of flow cytometry-based isolated pathogen-containing phagosomes at The University of Manchester on FindAPhD.com
PhD Project - Proteomics analysis of flow cytometry-based isolated pathogen-containing phagosomes at The University of Manchester, listed on FindAPhD.com
www.findaphd.com
December 15, 2025 at 12:15 PM
rdunwin.bsky.social
2 adjacent papers in my timeline with new AD biomarkers.

First claims 'accurate prediction'. Second claims 'prognosic value'.

First has an AUC of 0.769. Second has AUC 0.71 [95%CI 0.57–0.85]. Both values from the discovery cohort only.

Is it just me, or are these neither accurate or valuable?
December 11, 2025 at 8:41 AM
rdunwin.bsky.social
This is one of the funniest things I've read in ages... 🤣🤣👏👏
mrhenrymorris.substack.com Henry Morris @mrhenrymorris.substack.com · Dec 2
🚨Some personal news.

I'm thrilled to announce that I've just filed my first copy for The New Yorker.

A profile of Jonathan Gullis.

"You get the sense that offstage, Jonathan Gullis struggles with being Jonathan Gullis."

open.substack.com/pub/mrhenrym...
Jonathan Gullis, The Seagull's Lament
A New Yorker Profile
open.substack.com
December 2, 2025 at 9:16 PM
Reposted by Richard Unwin
cmichaelrose.bsky.social
I am looking for a PostDoc to join my group at Genentech to drive the development of proteomics technologies to fuel target and therapeutic discovery and development. Check out the link below!

careers.gene.com/us/en/job/20...
November 25, 2025 at 12:39 AM
rdunwin.bsky.social
November 24, 2025 at 8:44 PM
Reposted by Richard Unwin
fbmh-uom.bsky.social
The parents of a three-year-old boy born with a devastating, life-limiting genetic condition say they are now excited for his future after he received a revolutionary stem cell gene therapy treatment developed by researchers at the University of Manchester.
www.bbc.co.uk/news/article...
Hunter syndrome: Boy with rare condition amazes doctors after world-first gene therapy
Oliver has an inherited condition called Hunter syndrome, which causes progressive damage to the body and brain.
www.bbc.co.uk
November 24, 2025 at 11:31 AM
Reposted by Richard Unwin
femalesinms.bsky.social
Registration for the Round 6 of Mentorship Pods is now OPEN!

More info👉 femalesinms.com/mentorship-p...
Registration 👉 femalesinms.com/mentorship-p...
November 11, 2025 at 10:48 PM
rdunwin.bsky.social
This is an outstanding thread, and is spot on...

The drive towards open access/data sharing has been driven by funders. They're important, sure, but as an author I consider these more because my funder and employers expect it. The same people can lead to not-for-profit and quality over quantity.
hansonmark.bsky.social Mark A. Hanson @hansonmark.bsky.social · Nov 11
We wrote the Strain on scientific publishing to highlight the problems of time & trust. With a fantastic group of co-authors, we present The Drain of Scientific Publishing:

a 🧵 1/n

Drain: arxiv.org/abs/2511.04820
Strain: direct.mit.edu/qss/article/...
Oligopoly: direct.mit.edu/qss/article/...
A table showing profit margins of major publishers. A snippet of text related to this table is below. 1. The four-fold drain 1.1 Money Currently, academic publishing is dominated by profit-oriented, multinational companies for whom scientific knowledge is a commodity to be sold back to the academic community who created it. The dominant four are Elsevier, Springer Nature, Wiley and Taylor & Francis, which collectively generated over US$7.1 billion in revenue from journal publishing in 2024 alone, and over US$12 billion in profits between 2019 and 2024 (Table 1A). Their profit margins have always been over 30% in the last five years, and for the largest publisher (Elsevier) always over 37%. Against many comparators, across many sectors, scientific publishing is one of the most consistently profitable industries (Table S1). These financial arrangements make a substantial difference to science budgets. In 2024, 46% of Elsevier revenues and 53% of Taylor & Francis revenues were generated in North America, meaning that North American researchers were charged over US$2.27 billion by just two for-profit publishers. The Canadian research councils and the US National Science Foundation were allocated US$9.3 billion in that year. A figure detailing the drain on researcher time. 1. The four-fold drain 1.2 Time The number of papers published each year is growing faster than the scientific workforce, with the number of papers per researcher almost doubling between 1996 and 2022 (Figure 1A). This reflects the fact that publishers’ commercial desire to publish (sell) more material has aligned well with the competitive prestige culture in which publications help secure jobs, grants, promotions, and awards. To the extent that this growth is driven by a pressure for profit, rather than scholarly imperatives, it distorts the way researchers spend their time. The publishing system depends on unpaid reviewer labour, estimated to be over 130 million unpaid hours annually in 2020 alone (9). Researchers have complained about the demands of peer-review for decades, but the scale of the problem is now worse, with editors reporting widespread difficulties recruiting reviewers. The growth in publications involves not only the authors’ time, but that of academic editors and reviewers who are dealing with so many review demands. Even more seriously, the imperative to produce ever more articles reshapes the nature of scientific inquiry. Evidence across multiple fields shows that more papers result in ‘ossification’, not new ideas (10). It may seem paradoxical that more papers can slow progress until one considers how it affects researchers’ time. While rewards remain tied to volume, prestige, and impact of publications, researchers will be nudged away from riskier, local, interdisciplinary, and long-term work. The result is a treadmill of constant activity with limited progress whereas core scholarly practices – such as reading, reflecting and engaging with others’ contributions – is de-prioritized. What looks like productivity often masks intellectual exhaustion built on a demoralizing, narrowing scientific vision. A table of profit margins across industries. The section of text related to this table is below: 1. The four-fold drain 1.1 Money Currently, academic publishing is dominated by profit-oriented, multinational companies for whom scientific knowledge is a commodity to be sold back to the academic community who created it. The dominant four are Elsevier, Springer Nature, Wiley and Taylor & Francis, which collectively generated over US$7.1 billion in revenue from journal publishing in 2024 alone, and over US$12 billion in profits between 2019 and 2024 (Table 1A). Their profit margins have always been over 30% in the last five years, and for the largest publisher (Elsevier) always over 37%. Against many comparators, across many sectors, scientific publishing is one of the most consistently profitable industries (Table S1). These financial arrangements make a substantial difference to science budgets. In 2024, 46% of Elsevier revenues and 53% of Taylor & Francis revenues were generated in North America, meaning that North American researchers were charged over US$2.27 billion by just two for-profit publishers. The Canadian research councils and the US National Science Foundation were allocated US$9.3 billion in that year. The costs of inaction are plain: wasted public funds, lost researcher time, compromised scientific integrity and eroded public trust. Today, the system rewards commercial publishers first, and science second. Without bold action from the funders we risk continuing to pour resources into a system that prioritizes profit over the advancement of scientific knowledge.
November 12, 2025 at 7:45 AM